Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 293
Selected: 0
NCT IDTitle
NCT00638820Reduced Intensity AlloTransplant For Osteopetrosis
NCT02042924Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
NCT04714372FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
NCT01962636Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases
NCT02693665Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
NCT06544811American Indian Smokefree Native RCT
NCT02722668UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
NCT05363267NF-1, Nutraceutical Intervention
NCT01677949Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia
NCT04882423Vegetable Intake Effect on Heterocyclic Amine Metabolism
NCT05665543Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
NCT03081780Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML
NCT00331422Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT02145039Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases
NCT00625729Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
NCT00618540Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
NCT03316456Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction
NCT00620295Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
NCT00176865Stem Cell Transplant for Immunologic or Histiocytic Disorders
NCT00303719Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
NCT02309944Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients
NCT02227797MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
NCT03417154Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS
NCT04858594Study of Periodontitis and Blood Stream Infection in AML Patients Receiving Chemotherapy
NCT05338658Study of PAT in Patients With Solid Tumor Cancers
NCT02046291Safety of Romiplostim (Nplate®) Following UCBT
NCT00176904Stem Cell Transplant for Inborn Errors of Metabolism
NCT06692426Trial of Cell Based Therapy for DMD
NCT03294304BLASST-1 (Bladder Cancer Signal Seeking Trial): Nivolumab, Gemcitabine, and Cisplatin in Treatment of Muscle Invasive Bladder Cancer (MIBC) Undergoing Cystectomy
NCT00882206Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia
NCT05643014Observational Study of Exposure to Environmental Toxicants Among Firefighters
NCT00005998Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT01400672Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma
NCT02395822MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients
NCT02074631Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation
NCT06872333Allo HSCT for High Risk Hemoglobinopathies
NCT03152526CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploidentical Donor Natural Killer (NK) Cell Based Therapy for AML Patients Not in CR
NCT04740008Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices
NCT02118285Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT00602693T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
NCT01181258Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies
NCT03297463Radiation Therapy With Combination Immunotherapy for Relapsed/Refractory Metastatic Melanoma
NCT01106950Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML)
NCT05809557EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
NCT01593618Empowering Cancer Survivors Through Information Technology
NCT05708924MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT00400803Carboplatin and Gemcitabine With Bevacizumab Every 2 Weeks for Stage IIIb/IV Non-small Cell Lung Cancer
NCT02988466Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
NCT05973656Role of Acetaldehyde in the Development of Oral Cancer
NCT00006451Bone Marrow Transplantation in Treating Patients With Leukemia